Health systems and provider groups must pursue transformation to keep pace with the evolving healthcare ecosystem. Yet, disrupting oneself is fraught with challenges. How do you balance the "conflicting realities" of transformation and disruption? Our Chief Physician Executive Dr. Roger Ray threads the needle in this excerpt from Creating a New Healthcare.
The pandemic has brought disruptive changes to how and where patients access care. While many health systems have taken dramatic steps to meet these needs, organizations now must reconfigure their networks with a view of the considerable shifts in the demand model.
In times of crisis, it is often challenging to look beyond the emergency at hand. However, in the post-COVID-19 surge landscape, health systems have no choice. Here we summarize the current market state and highlight five imperatives that health systems must successfully navigate in the new reality.
For children's hospitals, COVID-19 has been materially disruptive – impacting both the health of pediatric populations as well as the health system bottom line. Children’s hospitals must continue to lead throughout this crisis, focusing on the health of children and the long-term sustainability of the child health ecosystem while at the same time taking immediate action to reopen services and close the budget gap created by the pandemic.
Listen to our webinar with Epstein Becker & Green and FocalPoint Partners, where we discussed how to navigate the ongoing COVID-19 uncertainty and intensifying levels of clinical, operational, and financial risk for independent hospitals.
The surge in Medicare Advantage enrollment has masked a concerning trend: For-profit health plans are far outpacing non-profits in capturing market share. With a renewed strategy, non-profits can narrow this gap.
While it is difficult to see past the current morass when in the middle of such an overwhelming crisis, some members of each AHS’s leadership team should be thinking about necessary actions to help the enterprise move forward and be prepared to act decisively when, or even before, the COVID-19 situation begins to improve.
Where can chemotherapy infusions be delivered safely? Many are re-examining the answer to that question in light of the evolving need for care delivery innovation that expands access to care while safeguarding the health of immunocompromised patients.
Make informed decisions about how you approach interoperability. Learn about the timelines and provider responsibilities, strategic benefits of thinking beyond compliance, and steps leaders need to take.
Non-traditional entities are capturing the value void through innovative models, partnering with funding entities to receive compensation for addressing needs. What activities and strategies should health systems consider?
Doubling down on ambulatory patient access and bolstering patient loyalty is more critical than ever for providers striving to retain and serve current patients, grow programs, and bend the cost curve.